Subscribe to our Newsletters !!

    Kumar Jeetendra

    Lupin in alliance with Natco receives FDA approval for Bosentan Tablets

    Mumbai, Baltimore, April 30, 2019: Lupin Limited (Lupin) in alliance with Natco Pharma (Natco) announced that it has received approval for Bosentan Tablets, 62.5 mg and 125 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Actelion Pharmaceuticals Limited’s Tracleer Tablets, 62.5 mg and 125 mg. rnrn Lupin

    Lifestyle factors affecting on reproductive function in male and female A Complete Review

    Introduction –rnInfertility is a worldwide issue affecting 15-18% of couples globally, amounting more than 45 million couples. In the era of increasing awareness, many things are changing and already changed. Fertility is the ability to produce offspring and clinical infertility is defined as the inability to get pregnant after 12 months of unprotected intercourse. Infertility

    Determination of Elemental Impurities in Antibiotics according to USP 232 and 233 by HR ICPOES

    As of January 2018, pharmaceutical products must comply with specified limits for the allowed exposure to certain trace elemental impurities. The maximum permitted exposure limits and the analytical methods in order to quantify the listed trace elemental impurities are described in the United States Pharmacopeia (USP) chapters Elemental Impurities – Limits[1] and Elemental Impurities –

    TCIs wide range of high quality condensing agents

    As a vital part of life and a versatile class of reactions, condensation reactions are an essential tool to connect molecules not only between amino acids, but also in the biosynthesis of fatty acids. Below, you'll find valuable information on TCI's wide range of high quality condensing agents such as TCFH, esterification organocatalyst, transesterification catalysts,

    Thermo Fisher Scientific Inaugurates New World Class Facility for Packaging and Distribution to Accelerate Clinical Trials Services in India

    Ahmedabad, India – (21 May 2019) – Thermo Fisher Scientific Inc. today announced the opening of a state-of-the-art packaging and distribution facility in Ahmedabad to better serve pharmaceutical customer growth in India and their increasing need for clinical trial support focused on local products for India’s market. The state-of-the art facility in the domestic tariff

    Dr Reddys Laboratories announces the relaunch of Zenatane in the US Market

    Hyderabad, India and Princeton, NJ, USA. June 3, 2019 — Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the re-launch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg a therapeutic equivalent generic version of Accutane®,

    Indias Biggest Pharma Expo in the National Capital

    Indian Pharma Expo 2019 is coming up on 16th, 17th & 18th July at Hall 12A Pragati Maidan, New Delhi. New Delhi: India’s famous Pharma event “Indian Pharma Expo 2019” will be inaugurated on 16th July at HALL No. 12A, Pragati Maidan, New Delhi. At the time of inauguration Key dignitaries from Department of Pharmaceuticals,

    DuPont Nutrition and Biosciences Introduces HOWARU PROTECT PRENATAL

    Delivering Clinically Documented Immune, Mood and Vaginal Benefits for Women During Pregnancy.rn WILMINGTON, Del., June 20, 2019 – DuPont Nutrition & Biosciences has announced the launch of HOWARU® Protect Prenatal+, an innovative probiotic formula that has been clinically proven to deliver mood, vaginal and immune health benefits for women during pregnancy and beyond. DuPont Nutrition

    Sun Pharma and China Medical System Holdings enter into a License Agreement for Cyclosporine A eye drops in Greater China

    Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO,Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that one of its wholly owned subsidiaries has entered into an exclusive licensing agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for the development and commercialization of Cyclosporine A